BioNTech SE (BNTX) reports strong revenue growth and pipeline progress, while navigating financial and legal hurdles.

Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on BioNTech SE (BNTX – Research Report). The associated price ...

John Newman, an analyst from Canaccord Genuity, maintained the Buy rating on BioNTech SE (BNTX – Research Report). The associated price ...

Announcement no. 12/20245 November 2024 Based on the preliminary financial results for Q3 2024 and developments during the first nine months of the year, which were impacted by the execution of strate ...

Net sales decreased to SEK 2,478m (2,697), corresponding to an organic decline of -6% (-19). Gross margin was 36.2% (36.6). Excl. items affecting comparability, the margin increased to 37.4% (36.6). O ...

Tens of thousands of U.S. citizens live in the Israeli-occupied territory, on opposing sides of an entrenched conflict, where neither Palestinians nor Israelis have much enthusiasm for Kamala ...

Two tragic incidents in Phuket resulted in the drowning deaths of a five year old Chinese boy and a 43 year old British tourist, police confirmed yesterday. Karon Police were notified by Chalong ...

Michigan Pension Fund Diversifies Crypto Holdings, Buys $10M in Ether ETFs ...